KRMD (KORU Medical Systems, Inc. Common Stock (DE)) Stock Analysis - Financials

KORU Medical Systems, Inc. Common Stock (DE) (KRMD) is a publicly traded Healthcare sector company. As of May 21, 2026, KRMD trades at $4.00 with a market cap of $175.92M and a P/E ratio of -80.40. KRMD moved +1.14% today. Year to date, KRMD is -28.19%; over the trailing twelve months it is +35.59%. Its 52-week range spans $1.86 to $6.61. Analyst consensus is strong buy with an average price target of $6.75. Rallies surfaces KRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are KRMD's key financials?

KRMD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. KRMD recently traded at $4.00. Market cap is $175.92M. P/E ratio is -80.40. Revenue is $43.26M.

KRMD Key Metrics

Key financial metrics for KRMD
MetricValue
Price$4.00
Market Cap$175.92M
P/E Ratio-80.40
EPS$-0.05
Dividend Yield0.00%
52-Week High$6.61
52-Week Low$1.86
Volume382
Avg Volume0
Revenue (TTM)$43.26M
Net Income$-2.28M
Gross Margin61.93%

KRMD Annual Financials

YearRevenueNet IncomeEPS
2025$41.13M$-2.64M$-0.06
2024$33.65M$-6.07M$-0.13
2023$28.52M$-13.74M$-0.30
2022$27.90M$-8.66M$-0.19

Latest KRMD News

Recent KRMD Insider Trades

  • Schiller Eric bought 5.00K (~$19.56K) on May 18, 2026.
  • Tharby Linda M bought 1.19K (~$4.67K) on May 15, 2026.
  • Tharby Linda M bought 1.19K (~$1.42M) on May 15, 2026.

KRMD Analyst Consensus

5 analysts cover KRMD: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.75.

Common questions about KRMD

What are KRMD's key financials?
KRMD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. KRMD recently traded at $4.00. Market cap is $175.92M. P/E ratio is -80.40. Revenue is $43.26M.
Is KRMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for KRMD. It does not provide personalized investment advice.
KRMD

KRMD